Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioAtla, Inc. BCAB

Set alert

Price alert · BCAB

All alert types
2.08 USD +0.01 +0.48%

As of Nov 3, 9:49 AM ET

Bid
3.55 × 995
Ask
3.68 × 100
2.08 Day range 2.08
1.07 52-week range 71.50
YTD
-92.68%
1 year
-94.05%
Open
2.08
Prev close
2.07
Mkt cap
3.47M
Vol
100
Avg vol
53.59K
EPS
-25.23
P/E
0.00
Div yield
0.00%
More statistics
Low
2.08
High
2.08
Forward P/E
-0.42
Beta
1.02
Short ratio
3.70
Inst. own
42.79%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.72
200-d avg
1.99
1y target
9.00

1Y chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Apr 6, 2026Split: 1 for 50
Signals (35)
NameDateAgo
SMA: BullishOct 26, 20261 week ago
MACD: Buy SignalSep 16, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
RSI: OversoldAug 28, 20262 months ago
MACD: Buy SignalAug 24, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
MACD: Buy SignalAug 10, 20262 months ago
SMA: BearishJul 20, 20263 months ago
MACD: Sell SignalJul 20, 20263 months ago
SMA: BullishJul 13, 20263 months ago
SMA: BearishJul 8, 20263 months ago
SMA: BullishJun 30, 20264 months ago
MACD: Buy SignalApr 17, 20266 months ago
RSI: OversoldApr 7, 20267 months ago
MACD: Sell SignalApr 6, 20267 months ago
RSI: OversoldFeb 12, 20268 months ago
MACD: Buy SignalFeb 4, 20269 months ago
MACD: Sell SignalFeb 3, 20269 months ago
RSI: OversoldJan 30, 20269 months ago
MACD: Buy SignalJan 23, 20269 months ago

Newest 20 of 35.

Analyst view

Consensus: none

Price target (mean) 9.00 +332.7% upside
Target (low)
5.00
Target (mean)
9.00
Target (high)
13.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 4
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BCAB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.34-0.34 – -0.33-0.56+39.3%00.0%3
Next quarter-0.39-0.39 – -0.39-0.48+18.8%00.0%1
Current year-1.48-1.48 – -1.46-2.58+42.6%11.00M0.0%3
Next year-1.31-1.51 – -1.02-1.48+11.5%0-100.0%3

Upgrades and downgrades

The latest rating changes

BCAB analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024HC Wainwright & Co.DowngradeBuyNeutral
Sep 16, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
May 23, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 28, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Mar 27, 2024HC Wainwright & Co.MaintainedBuyBuy
Dec 5, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Nov 8, 2023HC Wainwright & Co.MaintainedBuyBuy
Sep 25, 2023JP MorganMaintainedOverweightOverweight
Aug 2, 2023JP MorganMaintainedOverweightOverweight
Aug 2, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Aug 2, 2023EF HuttonReiteratedBuyBuy
Aug 2, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2023JMP SecuritiesReiteratedOutperformOutperform
May 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2023EF HuttonReiteratedBuyBuy
Apr 17, 2023EF HuttonMaintained—Buy
Apr 3, 2023JP MorganMaintained—Overweight
Mar 28, 2023BTIGMaintained—Buy
Mar 27, 2023JMP SecuritiesMaintained—Outperform
Mar 24, 2023Credit SuisseReiterated—Neutral
Mar 24, 2023EF HuttonReiterated—Buy
Mar 24, 2023HC Wainwright & Co.Maintained—Buy
Jan 5, 2023EF HuttonInitiated—Buy
Nov 4, 2022Credit SuisseMaintained—Neutral
Sep 15, 2022JMP SecuritiesInitiated—Market Outperform
Aug 10, 2022Credit SuisseMaintained—Neutral
Aug 10, 2022HC Wainwright & Co.Maintained—Buy
May 5, 2022Credit SuisseDowngradeOutperformNeutral
Mar 21, 2022HC Wainwright & Co.Initiated—Buy